Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Free Report) was the target of a significant increase in short interest in October. As of October 30th, there was short interest totaling 1,826,155 shares, an increase of 50.5% from the October 15th total of 1,213,493 shares. Based on an average trading volume of 23,351 shares, the short-interest ratio is presently 78.2 days.
Sumitomo Pharma Price Performance
Shares of Sumitomo Pharma stock opened at $11.91 on Wednesday. Sumitomo Pharma has a 12-month low of $8.40 and a 12-month high of $19.20. The company’s fifty day simple moving average is $10.59 and its two-hundred day simple moving average is $10.88.
Sumitomo Pharma Company Profile
Sumitomo Pharma Co., Ltd. is a Japanese pharmaceutical company engaged in the research, development, manufacture and commercialization of prescription medicines. Its portfolio and development activities have focused on psychiatric and neurological disorders, oncology, gynecological health and other areas of significant unmet medical need. The company also conducts research in regenerative medicine and cell therapy. The company has marketed medicines including Latuda (lurasidone), an antipsychotic used in the treatment of schizophrenia and bipolar depression, as well as products for conditions such as overactive bladder and other specialized therapeutic areas.
See Also
- Five stocks we like better than Sumitomo Pharma
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
